B A Barrow - JoVE Visualize

Showing results (1-10 of 8) with videos related to

Pageof 1

Sort By:

Diabetologia|February 1, 1997

Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDMJ Rachman, B A Barrow, J C Levy, et al.

Diabetologia|July 11, 2002

Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic siblingO M Herlihy, B A Barrow, P J Grant, et al.

Diabetes|October 6, 1997

Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapyJ Rachman, J C Levy, B A Barrow, et al.

Diabetes|November 1, 1996

Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDMJ Rachman, F M Gribble, B A Barrow, et al.

Diabetes Research and Clinical Practice|August 29, 2000

Parallel changes of proinsulin and islet amyloid polypeptide in glucose intoleranceC M MacNamara, B A Barrow, S E Manley, et al.

Diabetes Care|May 20, 1998

Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDMJ Rachman, M J Payne, J C Levy, et al.

Radiographics : a Review Publication of the Radiological Society of North America, Inc|May 1, 1994

Tibial plateau fractures: evaluation with MR imagingB A Barrow, W A Fajman, L M Parker, et al.

Diabetologia|June 1, 1995

Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetesJ A McLellan, B A Barrow, J C Levy, et al.

Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:

Pageof 1

Diabetologia|February 1, 1997

Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDMJ Rachman, B A Barrow, J C Levy, et al.

Diabetologia|July 11, 2002

Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic siblingO M Herlihy, B A Barrow, P J Grant, et al.

Diabetes|October 6, 1997

Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapyJ Rachman, J C Levy, B A Barrow, et al.

Diabetes|November 1, 1996

Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDMJ Rachman, F M Gribble, B A Barrow, et al.

Diabetes Research and Clinical Practice|August 29, 2000

Parallel changes of proinsulin and islet amyloid polypeptide in glucose intoleranceC M MacNamara, B A Barrow, S E Manley, et al.

Diabetes Care|May 20, 1998

Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDMJ Rachman, M J Payne, J C Levy, et al.

Radiographics : a Review Publication of the Radiological Society of North America, Inc|May 1, 1994

Tibial plateau fractures: evaluation with MR imagingB A Barrow, W A Fajman, L M Parker, et al.

Diabetologia|June 1, 1995

Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetesJ A McLellan, B A Barrow, J C Levy, et al.

Pageof 1